Your browser doesn't support javascript.
loading
Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions.
Jones, Melissa; Ionescu, Corina Mihaela; Walker, Daniel; Wagle, Susbin Raj; Kovacevic, Bozica; Chester, Jacqueline; Foster, Thomas; Johnston, Edan; Kuthubutheen, Jafri; Brown, Daniel; Atlas, Marcus D; Mikov, Momir; Mooranian, Armin; Al-Salami, Hani.
Affiliation
  • Jones M; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Ionescu CM; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Walker D; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Wagle SR; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Kovacevic B; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Chester J; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Foster T; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Johnston E; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Kuthubutheen J; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Brown D; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Atlas MD; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Mikov M; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
  • Mooranian A; Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
  • Al-Salami H; Hearing Therapeutics, Ear Science Institute Australia, Queen Elizabeth II Medical Centre, Perth, WA 6009, Australia.
Int J Mol Sci ; 23(2)2022 Jan 13.
Article in En | MEDLINE | ID: mdl-35055022
ABSTRACT
Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides' pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biguanides / Bile Acids and Salts / Drug Carriers / Drug Delivery Systems / Drug Compounding / Theranostic Nanomedicine Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biguanides / Bile Acids and Salts / Drug Carriers / Drug Delivery Systems / Drug Compounding / Theranostic Nanomedicine Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Australia